Concepedia

Author

Nabeela Khan

Memorial Sloan Kettering Cancer CenterORCID

Also Known As

N. Khan, Nabeela A. Khan, Nabeela Khan

109

Publications

940

Citations

13

H-Index

22

Concepts

All Affiliations

Memorial Sloan Kettering Cancer CenterDana-Farber Cancer InstituteUniversity of California San DiegoMoffitt Cancer CenterLa Jolla Institute for Immunology
NK

About

Nabeela Khan is an author at Memorial Sloan Kettering Cancer Center specializing in pathology, medicine, and urology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

3

3

85

2

Engineering

1

1

41

3

Public Health

1

1

17

4

Epidemiology

1

1

17

5

Nephrology

1

1

27

Nabeela Khan

×

9

Publications

684

Citations

9

H-Index

YearCitations

A Role for the Mouse 12/15-Lipoxygenase Pathway in Promoting Epithelial Wound Healing and Host Defense

Karsten Gronert, Neha Maheshwari, Nabeela Khan,

Journal of Biological Chemistry

2005

311

A Novel Mechanism Driving Poor-Prognosis Prostate Cancer: Overexpression of the DNA Repair Gene, Ribonucleotide Reductase Small Subunit M2 (RRM2)

Ying Z. Mazzu, Joshua Armenia, Goutam Chakraborty,

Clinical Cancer Research

2019

164

Transcriptomic Analysis of CD4+ T Cells Reveals Novel Immune Signatures of Latent Tuberculosis

Julie G. Burel, Cecilia S. Lindestam Arlehamn, Nabeela Khan,

The Journal of Immunology

2018

48

Ribonucleotide reductase small subunit M2 is a master driver of aggressive prostate cancer

Ying Z. Mazzu, Joshua Armenia, Subhiksha Nandakumar,

Molecular Oncology

2020

41

Single-cell profiling reveals distinct subsets of CD14+ monocytes drive blood immune signatures of active tuberculosis

Hannah Hillman, Nabeela Khan, Akul Singhania,

Frontiers in Immunology

2023

31

Intratumoral Sterol-27-Hydroxylase (<i>CYP27A1</i>) Expression in Relation to Cholesterol Synthesis and Vitamin D Signaling and Its Association with Lethal Prostate Cancer

Nabeela Khan, Konrad H. Stopsack, Emma H. Allott,

Cancer Epidemiology Biomarkers & Prevention

2019

28

Genomic alterations as predictors of survival among patients within a combined cohort with clear cell renal cell carcinoma undergoing cytoreductive nephrectomy

Daniel Tennenbaum, Brandon J. Manley, Emily C. Zabor,

Urologic Oncology Seminars and Original Investigations

2017

27

High prevalence of factor V Leiden and prothrombin G20101A mutations in Kashmiri patients with venous thromboembolism

Syed Shafia, Mahrukh Hameed Zargar, Nabeela Khan,

Gene

2018

17

Comprehensive Genomic Analysis of Metastatic Non–Clear-Cell Renal Cell Carcinoma to Identify Therapeutic Targets

Maria I. Carlo, Nabeela Khan, Ahmet Zehir,

JCO Precision Oncology

2019

17

Page 1